V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260010141 | 260012487 | 1.83 | null | null | 2018-06-17 | 2018-06-26 | IVADo | 2 | null | 260025727 | CARBOPLATIN + ETOPOSIDE |
| 260010142 | 260006397 | 1.76 | null | Curative (C) | 2017-07-01 | 2017-07-08 | EC | N | N | 260025887 | CETUXIMAB |
| 260010143 | 260006397 | 1.79 | 110 | Adjuvant (A) | 2017-09-24 | 2017-09-27 | Carboplatin + Pemetrexed | N | N | 260025887 | CISPLATIN + ETOPOSIDE |
| 260010144 | 260006398 | 1.71 | 70.2 | Palliative (P) | 2018-03-07 | 2018-03-22 | ETOPOSIDE | N | N | 260026055 | ETOPOSIDE |
| 260010145 | 260012489 | null | 70.7 | Not known (9) | 2016-10-22 | 2016-10-25 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | null | 260026057 | ETOPOSIDE |
| 260010146 | 260012489 | 1.83 | 86.5 | Palliative (P) | 2015-09-07 | 2015-09-07 | EP | N | N | 260026057 | CARBOPLATIN + ETOPOSIDE |
| 260010147 | 260006399 | 1.51 | 48 | Not known (9) | 2018-06-02 | 2018-06-16 | Rituximab | N | N | 260026217 | RITUXIMAB |
| 260010148 | 260006399 | 1.75 | null | Disease modification (D) | 2018-01-26 | 2018-01-26 | Cisplatin + Etoposide (3 day) | 2 | N | 260026217 | CARBOPLATIN + ETOPOSIDE |
| 260010149 | 260006399 | 1.98 | 72.2 | null | null | 2016-02-24 | 111 Trial (formerly BEP 111) | null | null | 260026217 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260010150 | 260006400 | 1.64 | 84 | Palliative (P) | 2018-02-10 | 2018-02-13 | 111 Trial (formerly BEP 111) | 02 | N | 260026662 | CISPLATIN + ETOPOSIDE |
| 260010151 | 260006401 | 1.67 | 66.8 | Curative (C) | 2018-05-07 | 2018-05-17 | Carboplatin + Etoposide IV 3 day | N | N | 260026686 | CARBOPLATIN + ETOPOSIDE |
| 260010152 | 260006401 | 1.8 | 69 | Curative (C) | 2015-03-26 | 2015-03-28 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260026686 | CISPLATIN + ETOPOSIDE |
| 260010153 | 260006401 | 1.85 | 90.7 | Palliative (P) | 2018-06-16 | 2018-07-08 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260026686 | GALLIUM TRIAL |
| 260010154 | 260006402 | 1.62 | 121 | Curative (C) | 2017-05-14 | 2017-05-14 | Rituximab | 2 | N | 260027259 | CISPLATIN + RT |
| 260010155 | 260006402 | 1.73 | 63.2 | Disease modification (D) | 2013-04-21 | 2013-04-27 | ETOPOSIDE | N | N | 260027259 | BENDAMUSTINE |
| 260010156 | 260006403 | null | 58.2 | Palliative (P) | 2016-08-16 | 2016-08-23 | FCR Oral - Cycle 1 | N | N | 260027489 | RITUXIMAB |
| 260010157 | 260006403 | 1.87 | 90 | Neo-adjuvant (N) | 2015-07-05 | 2015-09-28 | EP 1 2 or 3 day | N | N | 260027489 | CARBOPLATIN + ETOPOSIDE |
| 260010158 | 260006404 | 1.64 | null | Disease modification (D) | 2016-09-12 | 2016-09-18 | Rituximab | N | N | 260027663 | CARBOPLATIN + PACLITAXEL |
| 260010159 | 260006404 | 1.79 | 69.7 | Palliative (P) | 2018-01-27 | 2018-02-03 | CISPLATIN + ETOPOSIDE | N | N | 260027663 | CISPLATIN + ETOPOSIDE |
| 260010160 | 260006404 | 1.84 | 90 | Curative (C) | 2015-08-09 | 2015-08-15 | EP | N | N | 260027663 | IVA |
| 260010161 | 260006404 | 1.6 | 64.5 | Palliative (P) | 2017-12-04 | 2017-12-20 | CISPLATIN + ETOPOSIDE | 02 | null | 260027663 | ICE |
| 260010162 | 260006404 | 1.79 | 91 | Palliative (P) | 2015-05-17 | 2016-07-09 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260027663 | ABVD |
| 260010163 | 260006404 | 1.87 | 0 | Palliative (P) | 2016-09-06 | 2016-09-11 | CISPLATIN + ETOPOSIDE | N | N | 260027663 | CISPLATIN + ETOPOSIDE |
| 260010164 | 260006405 | 1.85 | 96.4 | Curative (C) | 2016-01-24 | 2016-02-07 | Rituximab | N | N | 260028027 | BLEOMYCIN + VINCRISTINE |
| 260010165 | 260006406 | 1.66 | 79 | Disease modification (D) | 2017-08-12 | 2017-09-11 | Rituximab | 02 | N | 260028496 | RITUXIMAB |
| 260010166 | 260006406 | 1.85 | null | Palliative (P) | 2013-11-26 | 2013-11-26 | Carboplatin + Etoposide IV 3 day | 02 | N | 260028496 | TIP |
| 260010167 | 260006406 | null | null | null | null | 2017-12-23 | EP 1 2 or 3 day | null | null | 260028496 | CISPLATIN + ETOPOSIDE |
| 260010168 | 260006406 | null | 56.6 | null | null | 2015-01-03 | Rituximab | N | N | 260028496 | CISPLATIN |
| 260010169 | 260006407 | null | 90 | Palliative (P) | 2015-11-04 | 2015-11-07 | ETOPOSIDE | N | N | 260029081 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260010170 | 260006407 | 1.7 | 83.6 | Curative (C) | 2016-09-06 | 2016-09-15 | CARBOPLATIN + GEMCITABINE | N | N | 260029081 | CARBOPLATIN + PACLITAXEL |
| 260010171 | 260006408 | 1.84 | 49.6 | Curative (C) | 2016-04-20 | 2016-04-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 260029516 | CISPLATIN + ETOPOSIDE |
| 260010172 | 260006409 | 1.72 | 88 | null | 2018-06-11 | 2018-06-11 | Trial Unspecified | 99 | N | 260029639 | CISPLATIN + ETOPOSIDE |
| 260010173 | 260006409 | 1.72 | 89 | Curative (C) | 2015-03-27 | 2015-04-06 | ETOPOSIDE | N | N | 260029639 | NOT MATCHED |
| 260010174 | 260006409 | 1.6 | 85.4 | Radical (R) | 2014-07-01 | 2014-07-14 | 111 Trial (formerly BEP 111) | N | N | 260029639 | CISPLATIN + ETOPOSIDE |
| 260010175 | 260006410 | 1.59 | 72.3 | Curative (C) | 2016-07-13 | 2016-07-13 | Rituximab | N | N | 260029897 | RITUXIMAB |
| 260010176 | 260006410 | null | 81.7 | Palliative (P) | 2015-08-22 | 2015-08-27 | BENDAMUSTINE | 2 | N | 260029897 | GEMCARBO |
| 260010177 | 260006411 | 1.81 | 69.8 | Curative (C) | 2017-04-06 | 2017-04-12 | TIP | 02 | 2 | 260030130 | CISPLATIN + ETOPOSIDE |
| 260010178 | 260006412 | 1.69 | 74.6 | Curative (C) | 2019-07-10 | 2019-07-17 | EP 1 2 or 3 day | N | N | 260000136 | EP |
| 260010179 | 260006412 | 1.55 | null | Disease modification (D) | 2019-05-19 | 2019-05-20 | CARBOPLATIN + GEMCITABINE | N | N | 260000136 | RITUXIMAB |
| 260010180 | 260006413 | 1.96 | null | Palliative (P) | 2015-03-14 | 2016-09-23 | CVP | N | N | 260001122 | CISPLATIN + ETOPOSIDE |
| 260010181 | 260006413 | 1.73 | 70 | Curative (C) | 2016-06-29 | 2016-07-03 | Rituximab | Y | N | 260001122 | CISPLATIN + RT |
| 260010182 | 260006414 | 1.85 | null | Curative (C) | 2015-04-07 | 2015-04-07 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | N | N | 260001891 | CISPLATIN + ETOPOSIDE |
| 260010183 | 260006414 | 1.7 | null | Curative (C) | null | 2016-02-14 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260001891 | RITUXIMAB |
| 260010184 | 260006414 | 1.56 | 87 | Curative (C) | 2017-11-24 | 2017-12-03 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | n | Y | 260001891 | EP |
| 260010185 | 260006415 | 1.68 | 68.5 | Adjuvant (A) | null | 2013-11-27 | Cisplatin | N | Y | 260002243 | CISPLATIN |
| 260010186 | 260006415 | 1.82 | null | null | 2017-12-07 | 2017-12-15 | RCEOP | 01 | null | 260002243 | EP |
| 260010187 | 260006415 | 1.85 | 73 | Curative (C) | 2017-09-28 | 2017-09-29 | EP 1 2 or 3 day | 02 | N | 260002243 | CISPLATIN + ETOPOSIDE |
| 260010188 | 260006415 | 1.7 | 67.7 | Curative (C) | 2019-01-03 | 2019-01-05 | Trial Unspecified | N | N | 260002243 | CARBOPLATIN + ETOPOSIDE |
| 260010189 | 260006415 | null | 74 | Palliative (P) | 2019-04-07 | 2019-04-07 | Cisplatin + Radiotherapy | null | N | 260002243 | CARBOPLATIN + PACLITAXEL |
| 260010190 | 260006416 | null | null | Curative (C) | 2019-01-18 | 2019-01-19 | Carboplatin + Etoposide IV 3 day | N | N | 260005100 | CHLORAMBUCIL + RITUXIMAB |